Cure8 research brief
IBD can cause cognitive and neurological symptoms. This preclinical study suggests a flavonoid-rich Chrysanthemum extract reduced colitis and related cognitive deficits in mice by changing the gut microbiota and activating brain neuroprotective signaling, which could point to new dietary-based research directions.
Researchers of microbiome–gut–brain interactions, preclinical IBD/neuroinflammation studies, clinicians following IBD comorbidities, and patients interested in experimental dietary interventions (with caution).
The paper describes preclinical (mouse) research showing a plant extract improved gut inflammation and cognitive behavior linked to colitis, and identifies microbiota changes and specific brain signaling pathways as potential mechanisms.
These findings are from an animal model and are hypothesis-generating for humans, not evidence that the extract is safe or effective in people with IBD. The study used DSS colitis, antibiotic depletion, and FMT to test necessity and sufficiency of the microbiota; it also profiled extract composition by LC–MS.
Outcomes included behavioral tests and molecular markers (LPS/TLR4/MyD88, BDNF/TrkB/CREB, 5-HT). The authors suggest development as a dietary intervention but clinical testing would be required.
Findings are from a DSS mouse model and supported by microbiota-depletion and FMT experiments; they are not clinical evidence. The abstract reports molecular and behavioral endpoints but does not provide human safety or efficacy data.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
The study suggests a rice bran extract might reduce colitis severity in rats by shifting gut microbiota and dampening TLR4/NF-κB–driven inflammation, a pathway relevant to human IBD research.
Vitamin D deficiency is common in people with IBD and may relate to disease activity, complications, and quality of life; understanding this link could influence monitoring and adjunctive care.
The study links a common plant compound (oxalate) to higher stool levels and worse inflammation in IBD, suggesting diet and gut handling of oxalate could affect disease activity and that microbiome-targeted strategies...
